Abstract: Our research focuses on the intersection of artificial intelligence (AI) and software development, particularly the role of AI models in automating code generation. With advancements in ...

We might earn a commission if you make a purchase through one of the links. The McClatchy Commerce Content team, which is independent from our newsroom, oversees this content. This article has ...

The adoption rate of AI tools has skyrocketed in the programming world, enabling coders to generate vast amounts of code with simple text prompts. Earlier this year, Google found that 90 percent of ...

Of all the possible applications of generative AI, the value proposition of using it to write code was perhaps the clearest. Coding can be slow and it requires expertise, both of which can be ...

All critical vulnerabilities in Microsoft, third-party, and open source code are eligible for rewards if they impact Microsoft services. Microsoft on Thursday announced a massive expansion to its bug ...

Microsoft now pays security researchers for finding critical vulnerabilities in any of its online services, regardless of whether the code was written by Microsoft or a third party. This policy shift ...

Recently, a friend asked me a question that's been floating around every boardroom and business school: "With AI writing code, does programming still matter?" It's a fair question. Generative AI can ...

HAMILTON, Ohio — A partnership between Miami University and iSpace offers free coding education to girls across the Tri-State, aiming to build essential computer science skills through hands-on ...

LAUSANNE, Switzerland — IOC leaders dropped wrestling from the Olympic program on Tuesday, a surprise decision that removes one of the oldest Olympic sports from the 2020 Games. The IOC executive ...

While cord-cutting has definitely had a major impact on the number of households with cable TV, there are still plenty of folks enjoying their favorite channels with coaxial and a set-top box. Cable ...

Rallybio Corporation (Nasdaq: RLYB), a clinical-stage biotechnology company translating scientific advances into transformative therapies for patients with devastating rare diseases, today announced ...